1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspectiveDelea, T.; El-Ouagari, K.; Karnon, J.; Sofrygin, O.
2008Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspectiveKarnon, J.; Delea, T.; Barghout, V.
2007Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancerDelea, T.; Karnon, J.; Sofrygin, O.; Thomas, S.; Papo, N.; Barghout, V.
2007Cost-effectiveness of letrozole in the extended adjuvant treatment of women with early breast cancerOuagari, K.; Karnon, J.; Delea, T.; Talbot, W.; Brandman, J.
2006Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancerDelea, T.; Karnon, J.; Smith, R.; Johnston, S.; Brandman, J.; Sung, J.; Goss, P.
2012Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumabDelea, T.; Tappenden, P.; Sofrygin, O.; Karnon, J.; Browning, D.; Amonkar, M.; Walker, M.; Cameron, D.
2007Conclusions regarding relative cost-utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are prematureDelea, T.; Karnon, J.; Goss, P.
2006Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: The UK perspectiveKarnon, J.; Delea, T.; Johnston, S.; Smith, R.; Brandman, J.; Sung, J.; Goss, P.

Discover